Kazuomi Kario Selected Research

Biomarkers (Surrogate Marker)

12/2021	Growth Differentiation Factor-15 Predicts Death and Stroke Event in Outpatients With Cardiovascular Risk Factors: The J-HOP Study.
1/2020	COVID-19 and hypertension-evidence and practical management: Guidance from the HOPE Asia Network.
11/2019	Association of calciprotein particles measured by a new method with coronary artery plaque in patients with coronary artery disease: A cross-sectional study.
10/2018	Effect of canagliflozin on nocturnal home blood pressure in Japanese patients with type 2 diabetes mellitus: The SHIFT-J study.
7/2018	Correlation between B-Type Natriuretic Peptide and N-Terminal pro-B-Type Natriuretic Peptide in a Large Japanese Population at Risk of Stage A Heart Failure.
11/2017	Association Between Waist-to-Height Ratio and Endothelial Dysfunction in Patients With Morbidity　- A Report From the FMD-J Study.
11/2017	Development of a New ICT-Based Multisensor Blood Pressure Monitoring System for Use in Hemodynamic Biomarker-Initiated Anticipation Medicine for Cardiovascular Disease: The National IMPACT Program Project.
1/2017	Hemodynamic Biomarker-Initiated Anticipation Medicine in the Future Management of Hypertension.
11/2016	Evidence and Perspectives on the 24-hour Management of Hypertension: Hemodynamic Biomarker-Initiated 'Anticipation Medicine' for Zero Cardiovascular Event.
1/2016	Rationale and design of a multicenter randomized controlled study to evaluate the preventive effect of ipragliflozin on carotid atherosclerosis: the PROTECT study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuomi Kario Research Topics

Disease

182	Hypertension (High Blood Pressure) 10/2022 - 05/2002
63	Stroke (Strokes) 06/2022 - 01/2002
40	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 10/2002
23	Heart Failure 11/2022 - 07/2008
16	Essential Hypertension 10/2022 - 05/2002
15	Masked Hypertension 01/2021 - 04/2007
15	Atrial Fibrillation 01/2021 - 01/2011
14	Type 2 Diabetes Mellitus (MODY) 01/2021 - 04/2004
14	Diabetes Mellitus 01/2019 - 10/2004
13	Cerebral Hemorrhage 12/2015 - 09/2009
11	Atherosclerosis 04/2022 - 10/2004
11	Chronic Renal Insufficiency 01/2021 - 04/2007
10	Sleep Apnea Syndromes (Sleep Apnea) 01/2022 - 09/2006
10	Myocardial Infarction 01/2021 - 01/2010
10	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 11/2009
10	Inflammation (Inflammations) 01/2016 - 03/2007
9	Hypoxia (Hypoxemia) 01/2021 - 11/2005
9	Ischemic Stroke 01/2020 - 02/2004
9	Cerebral Infarction 06/2012 - 10/2003
8	Hyperuricemia 04/2022 - 11/2019
8	Acute Coronary Syndrome 11/2021 - 01/2005
8	Body Weight (Weight, Body) 01/2021 - 05/2010
8	White Coat Hypertension 01/2020 - 01/2007
8	Obesity 01/2019 - 06/2008
7	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2022 - 10/2004
6	Apnea 01/2022 - 09/2006
6	Obstructive Sleep Apnea 01/2022 - 01/2016
6	Cognitive Dysfunction 11/2018 - 07/2008
6	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2018 - 04/2010
6	Isolated Systolic Hypertension 01/2018 - 01/2015
5	Thrombosis (Thrombus) 01/2021 - 04/2017
5	Tachycardia (Tachyarrhythmias) 01/2020 - 12/2005
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 05/2007
5	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2018 - 07/2002
5	Insulin Resistance 07/2011 - 01/2007
4	COVID-19 10/2022 - 01/2020
4	Carotid Artery Diseases 04/2022 - 01/2012
4	Cardiac Arrhythmias (Arrythmia) 11/2020 - 07/2010
4	Dementia (Dementias) 01/2020 - 02/2010
4	Hyperlipidemias (Hyperlipidemia) 01/2019 - 10/2004
4	Transient Ischemic Attack 01/2019 - 08/2015
4	Albuminuria 11/2013 - 06/2006
3	Coronary Disease (Coronary Heart Disease) 01/2022 - 04/2011
3	Heart Diseases (Heart Disease) 01/2022 - 12/2005
3	Hematoma 04/2021 - 12/2012

Drug/Important Bio-Agent (IBA)

80	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 01/2002
21	SaltsIBA 06/2022 - 11/2008
17	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2007
16	4- (2- (4- hydroxybenzyl)- phenoxy)- N- methylbutylamineIBA 01/2022 - 05/2015
14	Pharmaceutical PreparationsIBA 08/2022 - 04/2011
12	olmesartanIBA 01/2022 - 04/2011
12	salicylhydroxamic acid (SHAM)IBA 01/2022 - 01/2016
12	Angiotensin Receptor AntagonistsIBA 01/2021 - 04/2009
12	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2013 - 06/2008
12	C-Reactive ProteinIBA 06/2013 - 03/2007
11	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2022 - 01/2008
11	Glucose (Dextrose)FDA LinkGeneric 11/2018 - 01/2007
11	Amlodipine (Norvasc)FDA LinkGeneric 01/2018 - 05/2002
10	Neprilysin (Neutral Endopeptidase)IBA 01/2022 - 02/2014
10	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 02/2014
10	DiureticsIBA 01/2021 - 06/2010
9	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2022 - 02/2014
8	Uric Acid (Urate)IBA 01/2022 - 03/2017
8	Oxygen (Dioxygen)IBA 01/2022 - 11/2005
8	AnticoagulantsIBA 01/2021 - 01/2012
8	cilnidipineIBA 01/2021 - 12/2005
8	Warfarin (Coumadin)FDA LinkGeneric 01/2019 - 01/2012
7	pro-brain natriuretic peptide (1-76)IBA 11/2022 - 05/2014
7	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021 - 01/2016
7	Valsartan (Vals)FDA Link 01/2021 - 05/2007
7	AlbuminsIBA 01/2021 - 06/2008
7	CalciumIBA 01/2021 - 05/2002
7	omega-Chloroacetophenone (Mace)IBA 11/2020 - 01/2012
6	Febuxostat FDA Link 04/2022 - 01/2020
6	CholesterolIBA 01/2022 - 06/2006
6	CreatinineIBA 01/2021 - 08/2010
6	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2020 - 05/2002
6	Doxazosin (Cardura)FDA LinkGeneric 01/2017 - 08/2004
6	Indicators and Reagents (Reagents)IBA 01/2016 - 10/2003
5	SodiumIBA 01/2022 - 08/2008
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2020 - 05/2002
5	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2016 - 06/2002
5	Hemostatics (Antihemorrhagics)IBA 04/2015 - 10/2004
5	azelnidipineIBA 03/2013 - 06/2007
4	AldosteroneIBA 08/2022 - 01/2007
4	antineoplaston A10 (A 10)IBA 06/2022 - 12/2003
4	N-Type Calcium Channels (N-Type Calcium Channel)IBA 01/2021 - 12/2005
4	candesartanIBA 06/2014 - 10/2002
4	Adrenergic Agents (Adrenergic Drugs)IBA 12/2013 - 07/2002
4	Insulin (Novolin)FDA Link 06/2010 - 06/2006
3	Angiotensin IIIBA 01/2022 - 10/2002
3	Troponin T (Troponin T1)IBA 12/2021 - 05/2013

Therapy/Procedure

63	Therapeutics 10/2022 - 09/2002
34	Denervation 01/2022 - 06/2013
10	Catheters 01/2022 - 01/2016
10	Percutaneous Coronary Intervention 09/2021 - 01/2012
6	Drug Therapy (Chemotherapy) 01/2022 - 09/2011
6	Stents 04/2021 - 01/2012
4	Continuous Positive Airway Pressure 01/2022 - 07/2014
3	Blood Pressure Monitors 01/2021 - 12/2016